A new era of treating neurological diseases at the blood-brain-immune interface
A group of scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.
Inmunología
Imaging study reveals microglia’s crucial role in preventing axonal degeneration following spinal cord injury
A collaborative effort between engineers and biologists at the Hong Kong University of Science and Technology (HKUST) has uncovered a neuroprotective mechanism in spinal cord injury (SCI), shedding new light on therapeutic approaches to potentially ben…
Immune sensitivity links race and survival after prostate cancer immunotherapy
Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.
Biomarker may predict immunotherapy response in liver cancer
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study.
Biomarker may predict immunotherapy response in liver cancer
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell Medicine investigators.
Scientists explore new mechanisms to combat glioblastoma
Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, according to the Centers for Disease Control and Prevention. While glioblastoma can be diagnosed at any age, it’s primarily diagnose…
Why do I have hay fever? I didn’t have it as a child
Hay fever (or allergic rhinitis) is a long-term inflammatory condition that’s incredibly common. It affects about one-quarter of Australians.
Immunotherapy boosts survival of advanced Hodgkin lymphoma in clinical trial
A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92%, suggesting a new standard therapy for the disease. The New England Journal of Medicine published the innov…
Exploring the current development and applications of monoclonal antibodies
A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been published in the journal Molecular Biomedicine.
Unique immune response in lupus paves the way for new treatments
Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according to a new study by Weill Cornell…